Skip to main content

Table 1 Input variables used in estimating health-related economic impact

From: Government use licenses in Thailand: an assessment of the health and economic impacts

Parameters

Values

References

Thai Gross Domestic Product (GDP) per capita (Baht)

135,220

[43]

Disability Adjusted Life Years

(DALYs) averted from EFV-based ARVs treatment

5.69

[44]

DALYs averted from NVP-based ARVs treatment

5.54

 

QALYs gained from LPV/r-based ARVs treatment

No-data

-

QALYs gained from indinavir/ritonavir (IDV/r)-based ARVs treatment

No-data

-

QALYs gained from clopidogrel plus aspirin, which is used for secondary prevention of ischemic heart disease

7.37

[45]

QALYs gained from aspirin alone, which is used for secondary prevention of ischemic heart disease

7.31

 

QALYs gained from letrozole for treatment of breast cancer

13.14

[46]

QALYs gained from tamoxifen for treatment of breast cancer

12.73

 

QALYs gained from docetaxel for treatment of breast cancer

0.87

[47]

QALYs gained from paclitaxel for treatment of breast cancer

0.66

 

QALYs gained from docetaxel for treatment of lung cancer

0.41

[48]

QALYs gained from pemetrexed for treatment of lung cancer

0.41

 

QALYs gained from erlotinib for treatment of lung cancer

0.42

[48]

QALYs gained from imatinib for treatment of Chronic Myeloid Leukemia (CML)

1.07

[49]

QALYs gained from imatinib for treatment of GIST

1.9

[50]